BRK.A vs. JNJ: Berkshire Hathaway vs. Johnson & Johnson Stock Comparison

Company Profile

Berkshire Hathaway (BRK.A) is classified in the Financials sector (Financial Services), whereas Johnson & Johnson (JNJ) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Johnson & Johnson (JNJ) trades around 6.93M shares per day on average, while Berkshire Hathaway (BRK.A) sees only 206 — a volume gap that can matter for position sizing, exit liquidity, and order execution.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Johnson & Johnson (JNJ) at 20.02% sits in the top ROE quartile, while Berkshire Hathaway (BRK.A) at 12.12% is closer to the peer norm — stronger capital efficiency for JNJ.

Johnson & Johnson (JNJ) at 16.20% retains a top-quartile share of revenue as profit, ahead of Berkshire Hathaway (BRK.A) at 22.30%, which keeps about the industry-typical share.

Johnson & Johnson (JNJ) at 25.74% operates in the top operating margin quartile, ahead of Berkshire Hathaway (BRK.A) at 32.56%, which runs around its industry’s norm.

Profitability Metrics

Growth

Johnson & Johnson (JNJ) at 6.05% is around its peer norm for revenue growth, while Berkshire Hathaway (BRK.A) at -3.23% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Johnson & Johnson (JNJ) at 90.50% sits in the top EPS growth quartile, while Berkshire Hathaway (BRK.A) at -24.78% is in the bottom quartile, showing a clear gap in earnings momentum.

Growth Metrics

Financial Strength

Johnson & Johnson (JNJ) shows current ratio of 1.02; Berkshire Hathaway (BRK.A) doesn’t get one — Financial Services balance sheets aren’t split into current and non-current buckets, so short-term liquidity there is judged through regulatory measures instead.

Johnson & Johnson (JNJ) shows debt-to-equity ratio of 0.55; for Berkshire Hathaway (BRK.A) the ratio is set aside — in Financial Services, balance-sheet leverage is part of the business model itself, so capital-adequacy measures do the job this ratio does elsewhere.

Financial Strength Metrics

Dividends

Berkshire Hathaway (BRK.A) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Johnson & Johnson (JNJ) reports a yield of 1.94%, ranking against industry peers normally.

Berkshire Hathaway (BRK.A) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Johnson & Johnson (JNJ) reports a payout of 80.12%, ranking against industry peers normally.

Dividend Metrics

Valuation

Both Berkshire Hathaway (BRK.A) at 14.36 and Johnson & Johnson (JNJ) at 41.92 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

On P/S ratio, both Berkshire Hathaway (BRK.A) at 3.18 and Johnson & Johnson (JNJ) at 6.69 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

Berkshire Hathaway (BRK.A) at 1.72 is valued about in line with its industry on P/B ratio, while Johnson & Johnson (JNJ) at 8.16 carries an above-peer premium to book — JNJ is pricier on assets.

Valuation Metrics